Roivant Sciences Ltd reports results for the quarter ended in June - Earnings Summary

Roivant Sciences

08/08/2024 18:02

* Roivant Sciences Ltd  ROIV.OQ  reported quarterly adjusted
earnings of 12 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -38 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 26 cents per
share. Wall Street expected results to range from -32 cents
to -21 cents per share.
    * Revenue rose 155% to $55.13 million from a year ago;
analysts
expected $31.50 million. 
    * Roivant Sciences Ltd's reported EPS for the quarter was 12
cents​.
    * The company reported quarterly net income of $95.3
million.
    * Roivant Sciences Ltd shares had fallen by 3.8% this
quarter and
lost 9.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 43.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Roivant Sciences
Ltd is $17.50 
This summary was machine generated from LSEG data August 8 at
05:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.26          0.12           Beat
 Mar. 31 2024      -0.30          -0.19          Beat
 Dec. 31 2023      -0.32          -0.30          Beat
 Sep. 30 2023      -0.31          -0.40          Missed